+8.5%
GSK vs VRSN
+26.4%
-17.8%
-22.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | VRSN | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.4% | +0.2% | -0.5% | -0.4% |
| 7D | +0.2% | +1.4% | -1.2% | +0.2% |
| 30D | +5.4% | +3.9% | +1.5% | +5.3% |
| 3M | +0.9% | +9.3% | -8.4% | +0.9% |
| 6M | +0.7% | +6.7% | -5.9% | +0.8% |
| YTD | +5.6% | +30.0% | -24.4% | +5.2% |
| 1Y | +8.5% | +26.0% | -17.5% | +9.9% |
| All | +8.5% | +26.4% | -17.8% | +9.9% |
Cumulative growth
Daily Returns
Daily percentage return beside VRSN.
Daily Out/Under-Performance
Portfolio return minus VRSN return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × VRSN return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded VRSN wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling